![]()
|
|
||||||||
J. Biol. Chem., Vol. 275, Issue 30, 22619-22622, July 28, 2000
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
From the Laboratory of Apoptosis Regulation, Institute of Molecular and Cell Biology, 30 Medical Drive, Singapore 117609, Singapore
Received for publication, March 28, 2000, and in revised form, June 2, 2000
| |
ABSTRACT |
|---|
|
|
|---|
Cell death-inducing
DFF45-like effector (CIDE)-B is a member of the
novel family of apoptosis-inducing factors that share homology with the
N-terminal region of DFF, the DNA fragmentation factor. The molecular
mechanism of CIDE-B-induced apoptosis is unclear. We have shown here
that CIDE-B protein is localized in mitochondria and forms homodimers
and heterodimers with other family members. Serial deletion analyses
suggest that the mitochondria localization signal and dimerization
interface are overlapped and localized to the 30 amino acid residues at
the C-terminal region of CIDE-B. Mitochondria localization and
dimerization are both required for CIDE-B-induced apoptosis. Our study
has thus revealed a mechanism for CIDE-B-induced apoptosis by
localization to mitochondria and the formation of a high affinity homo-
or heterodimeric complex.
Mitochondria are major organelles that respond to death
stimuli by releasing factors such as cytochrome c and
apoptosis-inducing factor and altering the cellular
reduction-oxidation (redox) potential and oxidative phosphorylation
(1-3). A number of pro-and anti-apoptotic proteins reside in
mitochondria including various caspases (4), the ced-4 and
ced-9 (5) Bcl-2 family proteins (6), and the Nix
family proteins (7, 8). Mitochondria localization is important for the
anti-apoptotic activity of Bcl-2 (6) or the pro-apoptotic activity of
Nix (7, 8), as deletion of the C-terminal mitochondria localization
signal abrogates their activity. Many of the Bcl-2 family members can
form either homodimers or heterodimers with other family members (6, 9,
10). Activation of pro-apoptotic Bax appears to induce subcellular
translocation from cytosol to mitochondria as well as
homodimerization (11). Mutational analyses have revealed that the
conserved BH3 domain of the pro-apoptotic Bcl-2 family members such as
Bax plays an important role in mediating homo- or heterodimerization
(6).
The DNA fragmentation factor
(DFF)1 (12, 13) consists of
two subunits, a nuclease (CAD/DFF40) and its inhibitor (DFF45/ICAD). The N-terminal domain of DFF45 is required for its chaperone function by associating with the N-terminal region of DFF40 (14, 15). A novel
family of cell death-inducing
DFF45-like effectors (CIDEs) was identified by
its high homology with both of the N-terminal domains of DFF40 and
DFF45 (16, 17). CIDE proteins can be divided into the N-terminal CIDE-N
domain, which shares homology with DFF40/45, and the C-terminal CIDE-C
domain, which shares homology within CIDE proteins only (16). Although
this class of proteins shares homology with DFF45/40 at the N-terminal
region, their functions differ significantly. Unlike DFF45,
over-expression of CIDEs in mammalian cells shows strong cell
death-inducing activity with the C-terminal domain (CIDE-C) being
sufficient for its cell death activity (16). We have recently
participated in solving the structure of the N-terminal domain
of CIDE-B (or CIDE-N) (18). Our structural analyses suggested that
CIDE-N domains interact with each other with low affinity and that the
binding surface has a novel bipolar property consisting of two
oppositely charged regions. This novel homophilic association strongly
suggests that CIDE-N domain is a weak interaction interface functioning
as a regulatory domain for CIDE-B protein (18).
To gain insight into the molecular mechanism by which CIDE-B induces
apoptosis, we characterized its subcellular localization. We observed
that CIDE-B proteins are mitochondrially localized and form
homodimers and heterodimers with other family members. Systematic
deletion analysis showed that the C-terminal region of CIDE-B is
responsible for its mitochondria localization and dimerization. Our
data also suggest that both mitochondria localization and high affinity
interaction are required for CIDE-B-induced apoptosis. Therefore, CIDE
proteins form a novel family of pro-apoptotic mitochondrial proteins
that require dimerization to function.
Construction of Expression Plasmids--
The full-length and
truncated forms of CIDE-B were PCR-amplified using specific primers
corresponding to the regions described in Fig. 2A. All of
the PCR products contained NcoI at the 5'-end and
BamHI at the 3'-end. The PCR products were digested with
NcoI and BamHI and were then inserted in-frame
into pBluescript KS-Flag and pBluescript KS-HA to generate the 5'-Flag-
or HA-tagged fragments. The Flag- and HA-tagged inserts were then
digested with HindIII and XbaI and subcloned into
pCMV5 vector to produce the mammalian expression constructs. To make
the GFP-tagged proteins, fragments were blunted at the NcoI
site and subcloned into pEGFP-C3 (CLONTECH) at the
XhoI and BamHI sites. The validity of all the
constructs was confirmed by DNA sequencing.
Transient Transfection, Immunoprecipitation, and Western
Blotting--
6×105 human embryonic 293T cell were seeded
in 60-mm dish for 24 h prior to transfection. Cells were
co-transfected using Dosper liposomal transfection reagent (Roche
Molecular Biochemicals) following the manufacturer's
instruction. For Co-immunoprecipitation experiments, 4 µg of Flag-
and GFP-tagged CIDE-B and 24 µg of Dosper were added to one 60-mm
dish. Cells were washed once with ice-cold PBS and harvested in 300 µl of Triton X-100 lysis buffer (10 mM Tris (pH 7.4), 150 mM NaCl, 10 mM EDTA, 10 mM EGTA,
and 1% Triton X-100 containing 1 mM phenylmethylsulfonyl
fluoride, 10 mM dithiothreitol, 5 µg/ml aprotinin, 1 mg/ml leupeptin, and 1 mg/ml pepstatin) 20 h after transfection.
The cell lysate was incubated for 10 min on ice, sonicated, and
centrifuged for 30 min at 15,000 × g at 4 °C. A
50-µl aliquot of supernatant was mixed with 50 µl of 2× SDS
loading buffer, and 10 µl of the mixture was subjected to 15%
SDS-polyacrylamide gel electrophoresis to test the expression of
protein. The remaining supernatant was incubated with 10 µl of
anti-Flag M2-agarose affinity gel (Sigma) for 2 h at 4 °C.
After washing three times with Triton X-100 lysis buffer, the beads
were boiled in 50 µl of 1× SDS loading buffer and subjected to 15%
SDS-polyacrylamide gel electrophoresis. The proteins were transferred
to Hybond C membranes and immunoblotted with rabbit polyclonal
anti-OctA, anti-HA, and anti-GFP antibodies (all from Santa Cruz
Biotechnology), respectively. The proteins were detected by horseradish
peroxidase-conjugated secondary antibody (Bio-Rad) and visualized by
Super Signal reagent (Pierce).
Cell Death Assay--
3 × 105 CHO cells were
transfected with 0.5 µg of the reporter plasmid (pCMV
Mitochondria Localization--
3 × 105 COS-1
cells were transfected with 3 µg of GFP-CIDE-B or its truncations on
a 22 × 22-mm coverslip using Dosper. 23 h post-transfection,
cells were incubated with 100 nM MitoTracker (Molecular
Probes) for 30 min at 37 °C. Treated cells were fixed with 4%
paraformaldehyde-PBS for 20 min at room temperature and washed three
times with PBS. Cells were permeabilized in 0.2% Triton X-100 for 10 min, washed three times in 0.1% Triton X-100-PBS, rinsed three more
times with PBS, and visualized using a confocal microscope.
To characterize the subcellular localization of CIDE-B, the GFP
coding region was fused to the N-terminal ATG of human CIDE-B and transiently transfected into COS-1 cells to determine its localization. GFP fusion proteins of full-length CIDE-B were present in
punctate structures in cytoplasm. Co-staining these cells with MitoTracker showed a pattern similar to GFP-CIDE-B, and merging of the
two images showed almost completely overlapping patterns (Fig.
1). Co-staining of CIDE-B with Golgi or
endoplasmic reticulum-specific markers showed no overlapping
staining (data not shown). This specific localization was not due to
over-expression of GFP, as GFP alone showed a diffused distribution in
both the cytoplasm and nucleus with higher levels in the nucleus than
in the cytoplasm. Immunocytochemical staining with HA- and Flag-tagged
CIDE-B also showed overlapping expression patterns with MitoTracker
(data not show). Therefore, our data strongly indicate that CIDE-B
is localized to the mitochondria.
![]()
INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS AND DISCUSSION
REFERENCES
![]()
MATERIALS AND METHODS
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS AND DISCUSSION
REFERENCES
-galactosidase) plus 3 µg of CIDE-B expression plasmid in a 6-well
tissue culture dish using Dosper. 24 h post-transfection, cells
were fixed in 4% paraformaldehyde-PBS for 20 min at room temperature
and stained with
5-bromo-4-chloro-3-indolyl-
-D-galactopyranoside (Sigma)
at 37 °C for 30 min. Approximately 300 blue cells were counted for
each transfection (n = 4) from random fields under phase contrast microscope. Apoptotic cells were distinguished based on
morphological alteration typical of adherent cells undergoing apoptosis
including becoming rounded, condensed, and detached from the dish. The
mean of this calculation was used to calculate the percentage of apoptosis.
![]()
RESULTS AND DISCUSSION
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS AND DISCUSSION
REFERENCES

View larger version (32K):
[in a new window]
Fig. 1.
Subcellular localization of GFP-CIDE-B and
its truncations in COS1 cells. Fields shown (magnification, 400×)
were visualized under a confocal microscope at appropriate wavelengths
for MitoTracker and GFP, and the two images were overlaid
(Merge).
The region(s) that is responsible for CIDE-B mitochondria localization
was further defined by generating GFP fusion proteins containing
truncated forms of CIDE-B (Fig.
2A). GFP fusion proteins containing the N-terminal region of CIDE-B (CIDE-B
C) showed a diffused pattern in both nucleus and cytoplasm. In contrast, GFP fused
to the C-terminal region of CIDE-B (CIDE-B
N) was found as
spherically shaped granules and was localized predominantly to
mitochondria (Fig. 1). Therefore, the mitochondria localization signal
appears to reside in the C-terminal region of CIDE-B. GFP fusion
proteins with a deletion of 30 residues from the N-terminal end of this
C-terminal domain (CIDE-B-(148-219)) were still localized to
mitochondria. However, deletion of the C-terminal 39 residues from the
C-terminal domain (CIDE-B-(118-180)) disrupted the mitochondria localization of GFP fusion proteins, suggesting that C-terminal is
required for mitochondria localization. Surprisingly, GFP fusion proteins containing the C-terminal 39 residues of CIDE-B alone (CIDE-B-(181-219)) were expressed evenly throughout the cytoplasm and
nucleus and were not localized to any organelle-like structure. GFP
fusion proteins containing CIDE-B regions from 118 to 148 (CIDE-B-(118-148)) or 148 to 180 (CIDE-B-(148-180)) did not show typical mitochondria localization either. To explore the possibility that disruption around amino acid 180 may result in abolishing the
mitochondria localization signal, we generated constructs that span the
region near amino acid 180. Indeed, GFP fusion proteins containing
regions from residue 166-219 (CIDE-B-(166-219)) or 148-195
(CIDE-B-(148-195)) all displayed mitochondria localization. The
minimal region tested that showed mitochondria localization by GFP
analysis consists of amino acid 166-195
(CIDE-B166-195, Fig. 1), indicating that residues
166-195 at the C-terminal domain of CIDE-B are necessary and
sufficient to target CIDE-B to mitochondria. Computer analysis of the
minimal mitochondria localization signal revealed that it contains a
long stretch of
-helical structure that may help CIDE-B to insert
into the mitochondria membrane.
|
Cell death stimuli such as staurosporine and etoposide did not induce GFP-CIDE-B translocation from mitochondria to the nuclei or cytosol (data not shown), suggesting that CIDE-B exerts its cell death function by localization to mitochondria. By localizing to mitochondria, CIDE-B may interact directly with Bcl-2 family proteins such as Bcl-2 and Bcl-XL to chelate anti-apoptotic proteins, thereby inducing apoptosis. It is also possible that CIDE-B may directly induce mitochondria change such as disruption of mitochondria membrane potential, induction of the production of reactive oxygen species, and the release of apoptosis-inducing factors.
Our previous biochemical and structural analyses suggested that the
N-terminal region of CIDEs acts as a weak interaction interface through
homophilic interaction, whereas synergistic and high affinity binding
requires the contribution of other domains (14, 18). To explore the
possibility that CIDE proteins also contain multiple interaction
domains, Flag-tagged CIDE-B was co-expressed with HA-tagged CIDE-B or
CIDE-A in 293T cells. Flag-CIDE-B was immunoprecipitated with
monoclonal antibodies against Flag epitope, and the co-precipitating
protein was detected with HA antibodies. HA-CIDE-B was co-precipitated
with Flag-CIDE-B but not with control proteins (Fig. 2B),
indicating a strong interaction of CIDE-B with itself. Although we
cannot exclude formation of high order oligomers, we assume and will
refer to this interaction as dimerization. The HA-tagged C-terminal
region of CIDE-B (HA-CIDE-B
N) but not the N-terminal region
(HA-CIDE-B
C) was co-precipitated with Flag-CIDE-B, indicating that
the C-terminal region of CIDE-B mediates stable dimer formation. This
result was further confirmed by cotransfecting HA-CIDE-B
N with
Flag-CIDE-B
N and Flag-CIDE-B
C, respectively. HA-CIDE-B
N was
co-immunoprecipitated only with Flag-CIDE-B
N and not with
Flag-CIDE-B
C (Fig. 2C). Reciprocal experiments using HA
antibodies to immunoprecipitate the complex and detecting the co-precipitated product with Flag antibodies yielded the same results
(data not shown). Similar experiments conducted between HA-CIDE-B and
Flag-CIDE-A suggested that CIDE-B also interacts with CIDE-A (Fig.
2D), mediated by the C-terminal region. Consistent with our
previous data, CIDE-B
C/CIDE-B
C interaction (Fig. 2C) was weak and not detectable by co-immunoprecipitation experiments (14,
18).
To further delineate regions within the C-terminal domain of CIDE-B
that are required for dimerization, we cotransfected the GFP-tagged
CIDE-C domain and various truncated forms with Flag-tagged CIDE-B into
293T cells. The Flag antibody-immunoprecipitated products were probed
using GFP antibodies to detect the co-precipitated proteins. In
agreement with the results shown above, the CIDE-B
N domain was found
bound to CIDE-B proteins (Fig.
3A, lane 2).
Deletion of the N-terminal 30 amino acids of the CIDE-B
N domain had
little effect on the homodimeric interaction, suggesting that amino
acid residues 148-219 contain the dimerization interface (Fig.
3A, lane 3). Deletion of the C-terminal 39 amino
acids almost completely abolished the homodimeric interaction (Fig.
3A, lane 4), suggesting that this region is
important in mediating the CIDE-B/CIDE-B interaction. GFP fusion
proteins containing the C-terminal 39 amino acids of CIDE-B
N alone,
the middle region (residue 148-180), or the N-terminal region
(residue 118-148) alone showed no binding activity to CIDE-B (Fig.
3A, lanes 5-7). To explore the possibility that
disruption at residue 180 may disrupt the interaction interface, we
tested the ability of GFP fusion proteins containing residues 166-219, 148-195, and 166-195 of CIDE-C domain to co-immunoprecipitate with
flag-CIDE-B. Indeed, GFP fusion proteins containing these regions all
showed weak binding activity to CIDE-B (Fig. 3A, lanes 8-10). These results (Fig. 3A) suggest that
the minimal region required for CIDE-B/CIDE-B interaction is from
residues 166-195 in the C-terminal region of CIDE-B.
Quantitative analysis suggested that CIDE-B
N and
CIDE-B-(148-219) showed much higher binding affinity to CIDE-B (27- or
20-fold higher amounts co-immunoprecipitated, respectively) compared
with CIDE-B-(166-195) (minimal region required for the interaction,
Fig. 3B). These data also suggested that residues upstream
or downstream of residues 166-195 are required for high affinity
CIDE-B/CIDE-B interaction. Interestingly, the dimerization interface
coincides with the mitochondria localization signal. Dimerization (or
higher order oligomerization) of CIDE-B may increase the local
concentration of this protein and help it to target to mitochondria and
effectively induce cell death.
|
As mitochondria are the major organelles mediating cell death signals
and activating the cell death machinery and dimerization is critical
for the function of many cell death proteins, we tested whether
mitochondria localization and dimerization of CIDE-B are required for
CIDE-B-induced apoptosis. The N-terminal domain of CIDE-B (CIDE-B
C)
showed no cell death effect, whereas the C-terminal domain (CIDE-B
N)
alone showed a level of cell death comparable to full-length CIDE-B (70 and 65%, respectively). A deletion of the N-terminal end of the
CIDE-B
N (CIDE-B-(148-219)) that showed mitochondria localization
and high affinity interaction was still effective in inducing apoptosis
(55%). CIDE-B with a deletion of the C-terminal 39 residues
(CIDE-B-(118-180)), which neither localized to mitochondria nor
dimerized with itself, showed no apoptotic activity (20%). Truncations
of CIDE-B protein (CIDE-B-(118-148), -(148-180), and -(181-219)),
which showed no mitochondria localization, all showed no activity in
triggering apoptosis. CIDE-B deletions that showed mitochondria
localization but had low affinity interaction (CIDE-B-(166-219),
-(148-195), and -(166-195)) all demonstrated weak apoptotic activity
slightly higher than the vector but significantly lower than that of
CIDE-B
N domain and CIDE-B-(148-219). The differences in cell death
effect is not due to protein expression levels, as CIDE-B and its
truncation mutants all showed a similar level of expression (Fig.
4, inset). Our data thus
suggest that the C-terminal domain of CIDE-B plays an important role
for CIDE-B-induced apoptosis by directly targeting CIDE-B to
mitochondria, mediating CIDE-B/CIDE-B interaction, and inducing
apoptosis. It is very interesting to identify the 30 amino acids (from
166 to 195) at the C-terminal region of CIDE-B as both the mitochondria
localization signal and the interaction interface. Single-point
mutations at this region that abolish one of the activities would be
useful in distinguishing these roles.
|
| |
ACKNOWLEDGEMENTS |
|---|
We are grateful to Lai Ping Yaw for providing valuable reagents and technical help. We also thank Dr. John McCarty for critical comments on the manuscript.
| |
FOOTNOTES |
|---|
* This research was funded by the National Science and Technology Board of Singapore.The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
To whom correspondence should be addressed. Tel.: 65-874-3375;
Fax: 65-779-1117; E-mail: mcblip@imcb.nus.edu.sg.
Published, JBC Papers in Press, June 2, 2000, DOI 10.1074/jbc.C000207200
| |
ABBREVIATIONS |
|---|
The abbreviations used are: DFF, DNA fragmentation factor; CIDE, cell death-inducing DFF45-like effector; PCR, polymerase chain reaction; GFP, green fluorescent protein; PBS, phosphate-buffered saline; CHO, Chinese hamster ovary.
| |
REFERENCES |
|---|
|
|
|---|
| 1. | Green, D. R., and Reed, J. C. (1998) Science 281, 1309-1312 |
| 2. | Li, P., Jijhawan, D., Budihardjo, I., Srinivasula, S. M., Ahmad, M., Alnemri, E. S., and Wang, X. (1997) Cell 91, 479-489 |
| 3. | Susin, S. A., Lorenzo, H. K., Zamzami, N., Marzo, I., Snow, B. E., Brothers, G. M., Mangion, J., Jacotot, E., Costantini, P., Loeffler, M., Larochette, N., Goodlett, D. R., Aebersokd, R., Siderovski, D. P., Penninger, J. M., and Kroemer, G. (1999) Nature 397, 441-446 |
| 4. | Porter, A. G. (1999) Trends Cell Biol. 9, 394-401 |
| 5. | Chen, F., Hersh, B. M., Conradt, B., Zhou, Z., Riemer, D., Gruenbaum, Y., and Horvitz, H. R. (2000) Science 287, 1485-1489 |
| 6. | Gross, A. G., McDonnell, J. M., and Korsmeyer, S. J. (1999) Genes Dev. 13, 1899-1911 |
| 7. | Yasuda, M., Theodorakis, P., Subramanian, T., and Chinnadurai, G. (1998) J. Biol. Chem. 273, 12415-12421 |
| 8. | Chen, G., Cizeau, J., Velde, C. V., Park, J. H., Bozek, G., Bolton, J., Shi, L., Dubik, D., and Greenberg, A. (1999) J. Biol. Chem. 274, 7-10 |
| 9. | Ray, R., Chen, G., Vande, V. C., Cizeay, J., Park, J. H., Reed, J. C., Gietz, R. D., and Greenberg, A. H. (2000) J. Biol. Chem. 275, 1439-1448 |
| 10. | Gross, A., Jockel, J., Wei, MC., and Korsmeyer, S. J. (1998) EMBO J. 17, 3878-3885 |
| 11. | Hsu, Y.-T., Wolter, K. G., and Youle, R. J. (1997) Proc. Natl. Acad. Sci. U. S. A. 94, 3668-3672 |
| 12. | Enari, M., Sakahira, H., Okawa, O., Iwamatsu, A., and Nagata, S. (1998) Nature 391, 43-50 |
| 13. | Liu, X., Zou, H., Slaughter, C., and Wang, X. (1997) Cell (1997) 89, 175-184 |
| 14. | McCarty, J. S., Toh, S. Y., and Li, P. (1999) Biochem. Biophys. Res. Commun. 264, 176-180 |
| 15. | McCarty, J. S., Toh, S. Y., and Li, P. (1999) Biochem. Biophys. Res. Commun. 264, 181-185 |
| 16. | Inohara, N., Koseki, T., Chen, S., Wu, X., and Nunez, G. (1998) EMBO J. 17, 2526-2533 |
| 17. | Inohara, N., and Nunez, G. (1999) Cell Death Differ. 6, 823-824 |
| 18. | Lugovskoy, A. A., Zhou, P., Chou, J. J., McCarty, J. S., Li, P., and Wagner, G. (1999) Cell 99, 747-755 |
This article has been cited by other articles:
![]() |
V. Puri, S. Ranjit, S. Konda, S. M. C. Nicoloro, J. Straubhaar, A. Chawla, M. Chouinard, C. Lin, A. Burkart, S. Corvera, et al. Cidea is associated with lipid droplets and insulin sensitivity in humans PNAS, June 3, 2008; 105(22): 7833 - 7838. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Keller, J. T. Petrie, P. De Rose, I. Gerin, W. S. Wright, S.-H. Chiang, A. R. Nielsen, C. P. Fischer, B. K. Pedersen, and O. A. MacDougald Fat-specific Protein 27 Regulates Storage of Triacylglycerol J. Biol. Chem., May 23, 2008; 283(21): 14355 - 14365. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Y. Kim, K. Liu, S. Zhou, K. Tillison, Y. Wu, and C. M. Smas Assessment of fat-specific protein 27 in the adipocyte lineage suggests a dual role for FSP27 in adipocyte metabolism and cell death Am J Physiol Endocrinol Metab, April 1, 2008; 294(4): E654 - E667. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Z. Li, J. Ye, B. Xue, J. Qi, J. Zhang, Z. Zhou, Q. Li, Z. Wen, and P. Li Cideb Regulates Diet-Induced Obesity, Liver Steatosis, and Insulin Sensitivity by Controlling Lipogenesis and Fatty Acid Oxidation Diabetes, October 1, 2007; 56(10): 2523 - 2532. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Erdtmann, N. Franck, H. Lerat, J. Le Seyec, D. Gilot, I. Cannie, P. Gripon, U. Hibner, and C. Guguen-Guillouzo The Hepatitis C Virus NS2 Protein Is an Inhibitor of CIDE-B-induced Apoptosis J. Biol. Chem., May 9, 2003; 278(20): 18256 - 18264. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Francioso, F. Carinci, L. Tosi, L. Scapoli, F. Pezzetti, E. Passerella, R. Evangelisti, A. Pastore, S. Pelucchi, A. Piattelli, et al. Identification of Differentially Expressed Genes in Human Salivary Gland Tumors by DNA Microarrays Mol. Cancer Ther., May 1, 2002; 1(7): 533 - 538. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Chen, H. He, S. Zhan, S. Krajewski, J. C. Reed, and R. A. Gottlieb Bid Is Cleaved by Calpain to an Active Fragment in Vitro and during Myocardial Ischemia/Reperfusion J. Biol. Chem., August 10, 2001; 276(33): 30724 - 30728. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |